DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells.
(22/05/2003)
Detail
In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3.
(22/05/2003)
Detail
Induction of differentiation by 1alpha-hydroxyvitamin D(5) in T47D human breast cancer cells and its interaction with vitamin D receptors.
(22/05/2003)
Detail
Induction of apoptosis by vitamin D3 analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase.
(22/05/2003)
Detail
The role of vitamin D in prostate cancer.
(22/05/2003)
Detail
A phase one study of the hepatic arterial administration of 1,25-dihydroxyvitamin D3 for liver cancers.
(22/05/2003)
Detail
Mild heat shock induces proliferation, alkaline phosphatase activity, and mineralization in human bone marrow stromal cells and Mg-63 cells in vitro.
(22/05/2003)
Detail
A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer.
(22/05/2003)
Detail
Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium.
(22/05/2003)
Detail
Vitamin D analogs: mechanism of action and therapeutic applications.
(22/05/2003)
Detail
Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1.
(22/05/2003)
Detail
Correlation between induction of the mac25 gene and anti-proliferative effects of 1alpha,25(OH)2-D3 on breast cancer and leukemic cells.
(22/05/2003)
Detail
Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis.
(22/05/2003)
Detail
Selected micronutrients and oral and pharyngeal cancer.
(22/05/2003)
Detail
1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis model.
(22/05/2003)
Detail